The potential insights of Traditional Chinese Medicine on treatment of COVID-19
Tóm tắt
Corona Virus Disease 2019 (COVID-19) broke out in 2019 and spread rapidly around the world. There is still no specific antiviral therapy to the current pandemic. In China, historical records show that Traditional Chinese Medicine (TCM) is effective in prevention and enhancing the resistance to pandemic with unique insights. To fight with COVID-19, National Health and Commission of PRC has recommended some TCM in the guideline, such as HuoxiangZhengqi, LianhuaQingwen ShufengJiedu and XueBijing, and actually displayed a remarkable effect in clinical treatment strategic for COVID-19. We review studies to provide an in-depth understanding into the effect of TCM, and also introduce the possible mechanism involved in COVID-19 treatment.
Từ khóa
Tài liệu tham khảo
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Li H, Lu CZ, Tang KC. Clinical observation on treatment of SARS with combination of chaihu droplet pill and huoxiangzhengqi droplet pill. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004;24:321–4.
Zhang Z, Li X, Zhang W, Shi ZL, Zheng Z, Wang T. Clinical features and treatment of 2019-nCov pneumonia patients in Wuhan: report of a couple cases. Virol Sin. 2020. https://doi.org/10.1007/s12250-020-00203-8.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.
He YH, Zhao HY, Liu ZL, Lu C, Luo XJ, Lin SQ, et al. Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea. World J Gastroenterol. 2006;12(45):7346–9.
Deng YJ, Liu BW, He ZX, Liu T, Zheng RL, Yang AD, et al. Study on active compounds from Huoxiang Zhengqi Oral Liquid for prevention of coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking. Chin Tradit Herbal Drugs. 2020;51(5):1113–22.
Cheng DZ, Li Y. Clinical effectiveness and case analysis in 54 NCP patients treated with Lianhuaqingwen granules. World Chin Med. 2020;15(2):150–4.
Ling XY, Tao JL, Sun X, Yuan B. Exploring material basis and mechanism of Lianhua Qingwen prescription against coronavirus based on network pharmacology. Chin Tradit Herbal Drugs. 2020;51(7):1723–30.
Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105954.
Lin L, Dai F, Ren G, Wei J, Chen Z, Tang X. Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps. Am J Otolaryngol. 2020;41(1):102311.
Li RF, Hou YL, Huang JC, Pan WQ, Ma QH, Shi YX, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020. https://doi.org/10.1016/j.phrs.2020.104761.
Lin Q, Liao CX, Wei XH, Chen SY, Qian HJ. Therapeutic effect of LianhuaQingwen granule combined with sequential therapy of azithromycin on children mycoplasma pneumoniae pneumonia complicated with atelectasis and its effect on T lymphocyte subsets and inflammatory factors. Mod J of Integrated Tradi Chin Western Med. 2019;28(2):153–8.
Yao X, Cao LF, Yang J, Yao MX, Zhao L. Curative effect evaluation of ShufengJiedu Capsules for the treatment of acute exacerbation of chronic obstructive pulmonary disease. China J Tradit Chin Med Pharm. 2017;32(1):347–50.
Ji S, Bai Q, Wu X, Zhang DW, Wang S, Shen JL, et al. Unique synergistic antiviral effects of ShufengJiedu Capsule and oseltamivir in influenza a viral-induced acute exacerbation of chronic obstructive pulmonary disease. Biomed Pharmacother. 2020;121:109652.
Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14(1):64–8.
Qu XK, Hao SL, Ma JH, Wei GY, Song KY, Tang C, et al. Observation on clinical effect of Shufeng Jiedu Capsule combined with Arbidol Hydrochloride Capsule in treatment of COVID-19. Chin Tradit Herbal Drugs. 2020;51(5):1167–70.
Tao Z, Gao J, Zhang G, Xue M, Yang W, Tong C, et al. ShufengJiedu capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway. Biosci Trends. 2014;8(1):45–51.
Shen F, Fu ZY, Wu YR, Kuang GY, Li L, Zhu KM, et al. The potential targets and mechanisms of Shufeng Jiedu Capsule for novel coronavirus pneumonia (COVID-19) based on network pharmacology and molecular docking. Guiding J Tradit Chin Med Pharm. 2020;26(5):8–15.
Duan LM, Ning CZ. Observation curative effect of Xuebijing injection synergisticin treatment of acute exacerbation of chronic obstructive pulmonary disease. China Contin Med Educ. 2015;7(31):219–20.
Peng YQ, Mao YM, Zhu JQ, Chen H, Qiu XL, Jiang JH, et al. A clinical study of short-term Xuebijing injection on treatment of patients with acute exacerbation of chronic obstructive pulmonary disease. Chin J Integrated Tradit West Med Intensive Crit Care. 2008;15(3):178–80.
He TM, Duan CC, Li XF, Zhang JY. Potential mechanism of Xuebijing injection in treatment of coronavirus pneumonia based on network pharmacology and molecular docking. Chin J Mod Appl Pharm. 2020;37(4):398–405.
Sun MJ, Tu YR, OuYang HZ, Chang YX, He J. Effect of treatment with Xuebijing injection and its pharmacokinetics markers on serum inflammatory factor indude TNF-α, IL-1, IL-6, IL-8 and IL-10 in rats with sepsis. J Tianjin Univ Tradi Chin Med. 2018;37(1):13–5.
Zhang SW, Sun CD, Wen Y, Yin CH. Effect of treatment with Xuebijing injection on serum inflammatory mediators and Th1/2 of spleen in rats with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;18(11):673–6.
Dai XG, Yao YM, Ai YH. Effect of apoptosis of CD4 + CD25 + regulatory T lymphocytes on polarization of helper T lymphocytes and potential interventional influence of Xuebijing injectionin septic rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(3):135–8.
Dai XG, Yao YM, Ai YH. Effect of Xuebijing injection on lipopolysaccharide-induced apoptosis of CD4 + CD25 + regulatory T cells and immune function of effector T cells in vitro. Chin J Emerg Med. 2009;18(9):932–6.